Skip to main content
Clinical Trials/NCT01600768
NCT01600768UnknownNot Applicable

Evaluation of Extended Intravenous of Beta-lactams in the Treatment of Serious Gram-negative Infections in Critically Ill Patients

National Taiwan University Hospital1 site in 1 country100 target enrollmentStarted: February 2012Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Enrollment
100
Locations
1
Primary Endpoint
serum concentrations of beta-lactams

Study Overview

Brief Summary

The purpose of this study is to evaluate the PK/PD parameters, safety and efficacy of extended infusion of beta-lactams in intensive care patients who are infected with Gram-negative bacteremia or pneumonia at National Taiwan University Hospital (NTUH).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patients (> 18 years)
  • Admitted on the intensive care unit
  • Starting a treatment with beta-lactams antibiotics
  • Signed informed consent
  • Expected to live > 3 days

Exclusion Criteria

  • renal insufficiency (estimated clearance < 20 ML /MIN)
  • renal replacement therapy
  • ANC < 1000 103 µl
  • pregnancy
  • drug abuse

Arms & Interventions

intermittent infusion

Active Comparator

Intervention: Beta-Lactams (Drug)

extended infusion

Experimental

Intervention: Beta-Lactams (Drug)

Outcomes

Primary Outcomes

serum concentrations of beta-lactams

Time Frame: 6 hours

Determination of serum concentrations of beta-lactams

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials